DIVISLAB Income Statement - TTM - Divi's Laboratories Limited

Income Statement (TTM)

Divi's Laboratories Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	62,658	65,710	69,695	71,996	74,378	82,296	89,599	92,538	91,208	83,353	77,676	72,906	73,456	74,926	78,450	81,850	86,140	90,780	93,600	96,520
Change (%)		4.87	6.06	3.30	3.31	10.65	8.87	3.28	-1.44	-8.61	-6.81	-6.14	0.75	2.00	4.70	4.33	5.24	5.39	3.11	3.12
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	24,157	23,951	24,771	24,794	25,580	28,629	31,662	33,360	33,558	32,638	32,772	31,532	32,882	32,782	33,520	35,170	36,760	38,690	37,250	38,280
Change (%)		-0.85	3.42	0.09	3.17	11.92	10.59	5.36	0.59	-2.74	0.41	-3.78	4.28	-0.30	2.25	4.92	4.52	5.25	-3.72	2.77
% of Revenue	38.55	36.45	35.54	34.44	34.39	34.79	35.34	36.05	36.79	39.16	42.19	43.25	44.76	43.75	42.73	42.97	42.67	42.62	39.80	39.66

Gross Operating Profit	38,501	41,758	44,924	47,202	48,799	53,667	57,938	59,178	57,650	50,715	44,904	41,374	40,574	42,144	47,160	46,680	49,380	52,090	56,350	58,240
Change (%)		8.46	7.58	5.07	3.38	9.98	7.96	2.14	-2.58	-12.03	-11.46	-7.86	-1.93	3.87	11.90	-1.02	5.78	5.49	8.18	3.35
% of Revenue	61.45	63.55	64.46	65.56	65.61	65.21	64.66	63.95	63.21	60.84	57.81	56.75	55.24	56.25	60.11	57.03	57.33	57.38	60.20	60.34

SG&A	7,179	7,950	8,367	8,736	9,044	9,154	9,571	9,827	9,908	9,851	9,870	10,040	10,380	10,670	11,060	11,350	11,730	12,020	12,580	13,060
Change (%)		10.74	5.24	4.41	3.53	1.22	4.55	2.67	0.83	-0.58	0.20	1.72	3.39	2.79	3.65	2.62	3.35	2.47	4.66	3.82
% of Revenue	11.46	12.10	12.01	12.13	12.16	11.12	10.68	10.62	10.86	11.82	12.71	13.77	14.13	14.24	14.10	13.87	13.62	13.24	13.44	13.53

R&D
Change (%)
% of Revenue

OpEx	40,811	42,104	43,547	44,500	46,360	50,304	53,874	56,970	57,765	56,898	57,417	56,177	58,237	58,987	60,180	62,390	64,350	66,490	67,900	69,910
Change (%)		3.17	3.43	2.19	4.18	8.51	7.10	5.75	1.40	-1.50	0.91	-2.16	3.67	1.29	2.02	3.67	3.14	3.33	2.12	2.96
% of Revenue	65.13	64.08	62.48	61.81	62.33	61.13	60.13	61.56	63.33	68.26	73.92	77.05	79.28	78.73	76.71	76.22	74.70	73.24	72.54	72.43

Operating Income	21,847	23,605	26,148	27,497	28,019	31,992	35,726	35,568	33,443	26,454	20,259	16,729	15,219	15,939	18,310	19,460	21,790	24,290	25,700	26,610
Change (%)		8.05	10.77	5.16	1.90	14.18	11.67	-0.44	-5.98	-20.90	-23.42	-17.42	-9.03	4.73	14.88	6.28	11.97	11.47	5.80	3.54
% of Revenue	34.87	35.92	37.52	38.19	37.67	38.87	39.87	38.44	36.67	31.74	26.08	22.95	20.72	21.27	23.34	23.78	25.30	26.76	27.46	27.57

Interest Expense	-18	-5	-4	-4	-5	-4	-4	-2	-2	-1	-3	-3	-3	-3	-30	-30	-30	-30	-20	-50
Change (%)		-70.33	-27.78	12.82	11.36	-8.16	-17.78	-40.54	-18.18	-55.56	312.50	-0.00	-0.00	-0.00	809.09	-0.00	-0.00	-0.00	-33.33	150.00
% of Revenue	-0.03	-0.01	-0.01	-0.01	-0.01	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.04	-0.04	-0.03	-0.03	-0.02	-0.05

Net Income	17,590	18,705	19,843	20,493	21,362	25,678	29,604	31,054	29,925	23,970	18,234	14,774	13,314	13,834	16,000	16,740	18,360	20,670	21,910	23,060
Change (%)		6.34	6.08	3.28	4.24	20.20	15.29	4.89	-3.63	-19.90	-23.93	-18.98	-9.88	3.91	15.66	4.62	9.68	12.58	6.00	5.25
% of Revenue	28.07	28.47	28.47	28.46	28.72	31.20	33.04	33.56	32.81	28.76	23.47	20.26	18.12	18.46	20.40	20.45	21.31	22.77	23.41	23.89

Source: Capital IQ

Divi's Laboratories Limited - Income Statement (TTM)

Income Statement (TTM)

Other Listings